JILL GARRETH: Open Payments
NPI 1104278092 · RUSHVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 36 payments from 16 companies in 2025. Trend: 2023 $530 · 2024 $847 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $85 |
| ABBVIE INC. | 3 | $52 |
| Astellas Pharma US Inc | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Exact Sciences Corporation | 2 | $33 |
| Amgen Inc. | 2 | $33 |
| Lilly USA, LLC | 2 | $33 |
| Axsome Therapeutics, Inc. | 2 | $30 |
Products named: CAPLYTA, ELIQUIS, Veozah, FANAPT, REXULTI, VRAYLAR, The Cologuard Plus Collection Kit, MOUNJARO.
Industry payments across IN — which companies pay providers there.
